Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.
Lino RC, da Silva DPB, Florentino IF, da Silva DM, Martins JLR, Batista DDC, Leite KCS, Villavicencio B, Vasconcelos GA, Silva ALP, de Ávila RI, Verli H, Valadares MC, Gil ES, Vaz BG, Lião LM, Menegatti R, Costa EA.
Lino RC, et al. Among authors: valadares mc.
Eur J Pharm Sci. 2017 Aug 30;106:231-243. doi: 10.1016/j.ejps.2017.06.006.
Eur J Pharm Sci. 2017.
PMID: 28599988